During the past decade, Broome Oncology conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 18 clinical trials were completed, i.e. on average, 64.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 11 clinical trials were completed. i.e. 220% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Broome Oncology" #1 sponsor was "Bristol-Myers Squibb" with 12 trials, followed by "Eli Lilly and Company" with 6 trials sponsored, "Celgene" with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Eisai Inc." with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Broome Oncology" #1 collaborator was "Ono Pharmaceutical Co. Ltd" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Celgene Corporation" with 2 trials as a collaborator, "ARMO BioSciences" with 1 trials as a collaborator and "AbbVie" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Broome Oncology" are "Breast Cancer" (5 trials), "Non-Small Cell Lung Cancer" (5 trials), "Multiple Myeloma" (4 trials), "Non Small Cell Lung Cancer" (4 trials) and "Renal Cell Carcinoma" (3 trials). Many other conditions were trialed in "Broome Oncology" in a lesser frequency.

Most popular intervention types in "Broome Oncology" are "Drug" (34 trials), "Biological" (9 trials), "Other" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (14 trials), "Carboplatin" (6 trials), "Abemaciclib" (5 trials), "Docetaxel" (5 trials) and "Placebo" (5 trials). Other intervention names were less common.

The vast majority of trials in "Broome Oncology" are 41 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Broome Oncology". undefined are not yet recruiting, 5 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Broome Oncology, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Broome Oncology, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".